Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
25,441,646
-
Share change
-
-334,293
-
Total reported value
-
$1,601,845,507
-
Put/Call ratio
-
92%
-
Price per share
-
$62.96
-
Number of holders
-
181
-
Value change
-
-$82,212,688
-
Number of buys
-
76
-
Number of sells
-
116
Institutional Holders of INTERCEPT PHARMACEUTICALS IN - COM (ICPT) as of Q1 2020
As of 31 Mar 2020,
INTERCEPT PHARMACEUTICALS IN - COM (ICPT) was held by
181 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
25,441,646 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, STATE STREET CORP, Sarissa Capital Management LP, Senvest Management, LLC, MACQUARIE GROUP LTD, Bellevue Group AG, and FIRST TRUST ADVISORS LP.
This page lists
181
institutional shareholders reporting positions in this security
for the Q1 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.